CTLA-4 correlates with immune and clinical characteristics of glioma

BACKGROUND: CTLA-4 is a well-studied immune checkpoint protein that negatively regulates T cell-mediated immune responses. However, the expression of CTLA-4 in glioma and the effects of CTLA-4 on prognosis in patients with glioma have not yet been examined. METHODS: We investigated the protein level...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fangkun, Huang, Jing, Liu, Xuming, Cheng, Quan, Luo, Chengke, Liu, Zhixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945521/
https://www.ncbi.nlm.nih.gov/pubmed/31911758
http://dx.doi.org/10.1186/s12935-019-1085-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945521/
https://www.ncbi.nlm.nih.gov/pubmed/31911758
http://dx.doi.org/10.1186/s12935-019-1085-6

Ejemplares similares